Papers
11
Total Citations
118
H-Index
7
About
Marco Bandini is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for prostate and bladder cancers, particularly through the comparative effectiveness of robotic versus open surgical approaches. His work has fundamentally shaped the debate around minimally invasive techniques in complex oncologic procedures. Bandini’s most influential study, a population-based analysis of over 22,000 patients, demonstrated that robotic radical cystectomy offers superior perioperative outcomes compared to open surgery, including reduced complications and shorter hospital stays—a finding that has garnered 22 citations and influenced clinical guidelines. He has also critically examined the economic implications of robotic surgery, revealing significant regional disparities in hospital charges for robotic prostatectomy. Beyond comparative effectiveness, Bandini has challenged established paradigms, advocating for neoadjuvant immunotherapy in muscle-invasive bladder cancer and re-evaluating the role of cytoreductive prostatectomy in metastatic disease. His work on salvage lymph node dissection for recurrent prostate cancer has provided crucial insights into managing treatment-resistant disease. With over 100 citations across his top publications, Bandini’s research continues to drive evidence-based innovation in surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10